Bowden J, Holmes MV (2019) Meta-analysis and mendelian randomization: a review. Res Synth Methods 10(4):486–496. https://doi.org/10.1002/jrsm.1346

Article  PubMed  PubMed Central  Google Scholar 

Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512–525. https://doi.org/10.1093/ije/dyv080

Article  PubMed  PubMed Central  Google Scholar 

Burgess S, Thompson SG (2017) Interpreting findings from mendelian randomization using the MR-Egger method [published correction appears in. Eur J Epidemiol 2017;:] Eur J Epidemiol 32(5):377–389. https://doi.org/10.1007/s10654-017-0255-x

Article  PubMed  Google Scholar 

Burgess S, Butterworth A, Malarstig A, Thompson SG (2012) Use of mendelian randomisation to assess potential benefit of clinical intervention. BMJ 345:e7325. https://doi.org/10.1136/bmj.e7325

Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658–665. https://doi.org/10.1002/gepi.21758

Article  PubMed  PubMed Central  Google Scholar 

Burgess S, Daniel RM, Butterworth AS, Thompson SG, EPIC-InterAct Consortium (2015) Network mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. Int J Epidemiol 44(2):484–495. https://doi.org/10.1093/ije/dyu176

Article  PubMed  Google Scholar 

Burgess S, Davey Smith G, Davies NM et al (2023) Guidelines for performing mendelian randomization investigations: update for summer 2023. Wellcome Open Res 4:186. https://doi.org/10.12688/wellcomeopenres.15555.3

Article  PubMed  PubMed Central  Google Scholar 

Chiu HF, Ho SC, Chen CC, Yang CY (2011) Statin use and the risk of liver cancer: a population-based case–control study. Am J Gastroenterol 106(5):894–898. https://doi.org/10.1038/ajg.2010.475

Article  PubMed  Google Scholar 

Cho Y, Haycock PC, Sanderson E et al (2020) Exploiting horizontal pleiotropy to search for causal pathways within a mendelian randomization framework. Nat Commun 11(1):1010 Published 2020 Feb 21. https://doi.org/10.1038/s41467-020-14452-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui Z, Feng H, He B, He J, Tian Y (2021) Relationship between serum amino acid levels and bone Mineral density: a mendelian randomization study. Front Endocrinol (Lausanne) 12:763538 Published 2021 Nov 9. https://doi.org/10.3389/fendo.2021.763538

Article  PubMed  Google Scholar 

Davies NM, Holmes MV, Davey Smith G (2018) Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362(k601). https://doi.org/10.1136/bmj.k601. Published 2018 Jul 12

DiNicolantonio JJ, O’Keefe JH, Lavie CJ (2012) Benefits and risks of aspirin use. JAMA 308(11):1088–1090. https://doi.org/10.1001/2012.jama.10717

Article  CAS  PubMed  Google Scholar 

Drew DA, Chan AT (2021) Aspirin in the Prevention of Colorectal Neoplasia. Annu Rev Med 72:415–430. https://doi.org/10.1146/annurev-med-060319-120913

Article  CAS  PubMed  Google Scholar 

Fitzmaurice C, Abate D et al (2021) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study [published correction appears in JAMA Oncol. 2020;6(3):444] [published correction appears in JAMA Oncol. 2020;6(5):789] [published correction appears in JAMA Oncol. 2021;7(3):466]. JAMA Oncol. 2019;5(12):1749–1768. https://doi.org/10.1001/jamaoncol.2019.2996

Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67(1):358–380. https://doi.org/10.1002/hep.29086

Article  PubMed  Google Scholar 

Hemani G, Zheng J, Elsworth B et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7:e34408. https://doi.org/10.7554/eLife.34408. Published 2018 May 30

Article  PubMed  PubMed Central  Google Scholar 

Huang Z, Fang W, Liu W et al (2018) Aspirin induces beclin-1-dependent autophagy of human hepatocellular carcinoma cell. Eur J Pharmacol 823:58–64. https://doi.org/10.1016/j.ejphar.2018.01.031

Article  CAS  PubMed  Google Scholar 

Hwang IC, Chang J, Kim K, Park SM (2018) Aspirin use and risk of Hepatocellular Carcinoma in a National Cohort Study of Korean adults. Sci Rep 8(1):4968. https://doi.org/10.1038/s41598-018-23343-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iannacone M, Sitia G, Isogawa M et al (2005) Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med 11(11):1167–1169. https://doi.org/10.1038/nm1317

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kamat MA, Blackshaw JA, Young R et al (2019) PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics 35(22):4851–4853. https://doi.org/10.1093/bioinformatics/btz469

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim G, Jang SY, Han E et al (2017) Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study. Int J Cancer. 2017;140(4):798–806. https://doi.org/10.1002/ijc.30506

Kumar M, Zhao X, Wang XW (2011) Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? Cell Biosci 1(1):5. https://doi.org/10.1186/2045-3701-1-5. Published 2011 Jan 24

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurilshikov A, Medina-Gomez C, Bacigalupe R et al (2021) Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet 53(2):156–165. https://doi.org/10.1038/s41588-020-00763-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee TY, Hsu YC, Tseng HC et al (2019) Association of Daily Aspirin Therapy with Risk of Hepatocellular Carcinoma in patients with chronic Hepatitis B. JAMA Intern Med 179(5):633–640. https://doi.org/10.1001/jamainternmed.2018.8342

Article  PubMed  PubMed Central  Google Scholar 

Liao YH, Hsu RJ, Wang TH et al (2020) Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study. BMC Gastroenterol 20(1):6. https://doi.org/10.1186/s12876-020-1158-y. Published 2020 Jan 9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maini MK, Schurich A (2012) Platelets harness the immune response to drive liver cancer. Proc Natl Acad Sci U S A 109(32):12840–12841. https://doi.org/10.1073/pnas.1210296109

Article  PubMed  PubMed Central  Google Scholar 

Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the study of Liver diseases. Hepatology 68(2):723–750. https://doi.org/10.1002/hep.29913

Article  PubMed  Google Scholar 

McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of Hepatocellular Carcinoma. Hepatol 73 Suppl 1(Suppl 1):4–13. https://doi.org/10.1002/hep.31288

Article  CAS  Google Scholar 

Pang Q, Jin H, Qu K et al (2017) The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis. Onco Targets Ther 10:4645–4656 Published 2017 Sep 20. https://doi.org/10.2147/OTT.S143154

Article  PubMed  PubMed Central  Google Scholar 

Pavlovic N, Rani B, Gerwins P, Heindryckx F (2019) Platelets as key factors in Hepatocellular Carcinoma. Cancers (Basel) 11(7):1022. https://doi.org/10.3390/cancers11071022. Published 2019 Jul 20

Article  CAS  PubMed  Google Scholar 

Petrick JL, Sahasrabuddhe VV, Chan AT, Alavanja MC, Beane-Freeman LE, Buring JE, Chen J, Chong DQ, Freedman ND, Fuchs CS, Gaziano JM, Giovannucci E, Graubard BI, Hollenbeck AR, Hou L, Jacobs EJ, King LY, Koshiol J, Lee IM, Linet MS, McGlynn KA (2015) NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: the Liver Cancer Pooling Project. Cancer prevention research (Philadelphia, Pa. 8(12):1156–1162. https://doi.org/10.1158/1940-6207.CAPR-15-0126

Sahasrabuddhe VV, Gunja MZ, Graubard BI et al (2012) Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst 104(23):1808–1814. https://doi.org/10.1093/jnci/djs452

Article  CAS  PubMed